DanielC.AdelmanMD
Allergy & Immunology • San Francisco, CAProfessor, Internal Medicine, UCSF School of Medicine
Dr. Adelman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2725Fax+1 415-353-2568
Education & Training
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1983 - 1985
University of California, Davis, School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1984 - 2026- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors. Start of enrollment: 2004 Jun 01
- Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors Start of enrollment: 2004 Oct 01
- Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors Start of enrollment: 2006 Jan 01
Publications & Presentations
PubMed
- Exploratory immunogenicity outcomes of peanut oral immunotherapy: Findings from the PALISADE trial.Caroline Nilsson, Andrea Vereda, Magnus P Borres, Mats Andersson, Eva Södergren
Clinical and Translational Allergy. 2024-01-01 - 4 citationsParticipant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials.Christina Ciaccio, Alan B Goldsobel, Aikaterini Anagnostou, Kirsten Beyer, Thomas B Casale
Annals of Allergy, Asthma & Immunology. 2022-12-01 - 19 citationsOral desensitization therapy for peanut allergy induces dynamic changes in peanut-specific immune responses.Veronique Bajzik, Hannah A DeBerg, Nahir Garabatos, Blake J Rust, Kimberly K Obrien
Allergy. 2022-08-01
Press Mentions
Jasper Therapeutics Appoints Daniel Adelman, M.D., as Acting Chief Medical OfficerMarch 23rd, 2023- Largest European Qualitative Study on Peanut Allergy Highlights Negative Impact of Avoidance and Fear of Accidental Peanut Allergy Reactions on Allergic Individuals and Their CaregiversAugust 24th, 2020
- White House Left States on Their Own to Buy Ventilators; Inside Their Mad ScrambleJune 16th, 2020
- Join now to see all
Grant Support
- Impact Of Hormonal Changes On Asthma In WomenNational Institute Of Allergy And Infectious Diseases1994–1996
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
